{
  "author": {
    "name": "Yaacov Benmeleh",
    "webUrl": "/author/profile/yaacov-benmeleh/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2019/05/13/drugmakers-accused-of-generic-drug-price-fixing-in-new-antitrust-lawsuit/",
        "title": "Drugmakers accused of generic-drug price fixing in new antitrust lawsuit",
        "byline": "David McLaughlin and Yaacov Benmeleh",
        "kicker": "News",
        "prettyDate": "May 13, 2019",
        "timeToRead": "5 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/12/pill-money-investing-investments-health-pharma.jpg",
          "width": "616",
          "height": "411"
        },
        "authors": [
          {
            "webUrl": "/author/profile/david-mclaughlin/",
            "name": "David McLaughlin"
          },
          {
            "webUrl": "/author/profile/yaacov-benmeleh/",
            "name": "Yaacov Benmeleh"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "The lawsuit, filed by more than 40 state attorneys general, accuses the drugmakers of inflating prices of more than 100 drugs. ",
        "body": null
      }
    ]
  }
}